Wed, 12 Aug 2026 · LIVE
Updated Aug 11, 2026 · 19:25
Business India News Updated Aug 11, 2026

Medical Device Industry Seeks Separate Law, Urges Health Ministry to Reconsider Bill 2026

Eleven major healthcare and medical technology associations, led by the Association of Indian Medical Device Industry, have written to Union Health Minister JP Nadda urging a comprehensive re-examination of the Draft Drugs, Medical Devices and Cosmetics Bill, 2026. The coalition seeks a standalone regulatory architecture tailored exclusively to medical devices, arguing the current draft treats them as an adjunct to pharmaceuticals. The industry objects to criminal penalties for technical non-conformities and expanded enforcement powers, citing global standards like US FDA and EU MDR. They propose an autonomous National Medical Devices Regulatory Authority and multi-disciplinary expert committee to draft risk-proportionate penalties.

"Separate law needed": Medical device industry associations urge Health Ministry to reconsider draft bill 2026

New Delhi, August 11

Eleven major healthcare and medical technology associations, led by the Association of Indian Medical Device Industry, have jointly written to Union Minister of Health and Family Welfare JP Nadda, calling for a comprehensive re-examination of the proposed Draft Drugs, Medical Devices and Cosmetics Bill, 2026.

The coalition is seeking a standalone regulatory architecture tailored exclusively to medical devices.

The joint submission argued that the draft legislation continues to treat medical devices as an adjunct to pharmaceuticals, ignoring the fundamental scientific, structural, and engineering distinctions between drugs and medical technologies.

The industry emphasised that a dedicated Medical Devices Act would significantly cut India's heavy reliance on imports (currently estimated at 70-80%) while boosting domestic manufacturing and global competitiveness.

The demand is supported by recommendations from Parliamentary Standing Committee Reports 138 and 146, along with NITI Aayog's Draft Medical Devices Bill (2019).

The letter strongly objects to provisions imposing 1 to 7 years of imprisonment for technical non-conformities, such as labelling errors, documentation lapses, licensing issues, and post-market surveillance delays.

Industry bodies contend that such criminal liability contradicts global regulatory standards (such as US FDA and EU MDR), which prioritise administrative enforcement, quality management, and corrective recalls over penal actions.

The associations raised alarms over expanded arrest and enforcement powers for regulatory inspectors, warning that punitive approaches could create a climate of fear, deter foreign investment, and stifle domestic innovation.

The submission calls for formal legal recognition of device-specific engineering parameters, including biocompatibility, usability engineering, software lifecycle safety, remanufacturing, and predicate equivalence pathways.

The coalition urged the government to establish an autonomous National Medical Devices Regulatory Authority and constitute a multi-disciplinary expert committee--comprising biomedical specialists, clinicians, engineering experts, patient safety groups, and industry representatives--to draft risk-proportionate penalties based on product class and potential harm.

The industry associations have submitted clause-specific amendment proposals alongside international regulatory benchmarks, requesting structured stakeholder consultations before the Bill is finalised.

— ANI

Reader Comments

Sneha F

The prison term for labelling errors is absolutely ridiculous. Imagine a technician getting jailed for a typo in the instruction manual! We need strict regulation but also common sense. The government should listen to industry experts instead of just copying western laws blindly. This draft bill needs more work before it becomes law.

Arjun K

I work in a medical device startup and the current regulatory environment already makes it tough to innovate. If they add criminal penalties on top of that, no one will take the risk. We need a "Make in India" approach for healthcare, but that requires modernised rules, not outdated pharmaceutical thinking. NITI Aayog suggested a separate bill in 2019, why is the government sleeping on that? 🤔

Jennifer L

Interesting to follow this from abroad. The US and EU have completely different frameworks for medical devices, and it works well. India learning from that experience is smart. A standalone act with a proper regulatory authority could be a game changer for affordable healthcare in Asia. Hoping the Health Ministry takes this feedback seriously!

Kavya N

As a patient, I want safe devices but I also want them affordable. If we over-regulate, prices stay high because we keep importing from Germany or USA. A separate law is the only way to encourage local manufacturing. Also the fear of arrest will just discourage honest entrepreneurs. Shame on whoever drafted those penal provisions.

Manish T

The government should carefully weigh the risks. On one hand, we need stricter vigilance after some past medical device failures. But on the other hand, criminalising technical slip-ups is wrong

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Reader Voices

Leave a comment

Be kind. Add to the conversation. 0/50
Thank you — your comment has been submitted.
JS blocked